Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

CorMedix, Inc.

TRADE

AMEX: CRMDHealthcare / Biotechnology / USA
1.82-0.36-16.51%Vol 5 998 3851Y Perf 203.35%
Oct 16th, 2018 16:00
BID1.82 ASK1.86
Open1.85 Previous Close2.18
Pre-Market1.79 After-Trading1.88
 -0.39 -17.89%  0.06 3.30%
Target Price
3.00 
Analyst Rating
Strong Buy 1.00
Potencial %
64.84 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)178 
Earnings Rating
Buy
Price Range Ratio 52wk %
73.99 
Earnings Date
8th Nov 2018

Today's Price Range

1.662.00

 

52wk Range

0.172.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
225.00%
3 Months
600.00%
6 Months
766.67%
1 Year
203.35%
3 Years
-25.41%
5 Years
83.84%

Quotes

Name / TickerPriceChg.Chg.%
CRMD1.82-0.3600-16.51
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.40
Current Ratio 0.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -5 205.70
Leverage Ratio -1.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin64.40
EBIT Margin-21 155.00
EBITDA Margin-21 123.60
Pre-tax Profit Margin-99 381.60
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 60.71
PS Ratios 1 793.62
Price to Cash Flow -
Price to Free Cash Flow -11.70
Cash Flow Per Share -0.36
Price to Tangible Book-34.13
Book Value per Share-0.07
Enterprise Value (in ths.)216 427
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-178.89
ROE last 12 Months -844.75
Return on Assets (5Y Avg) -155.32
ROA last 12 Months -283.06
Return on Capital (5Y Avg) -
ROC last 12 Months -879.61
Return on invested Capital Q -253.90
Return on invested Capital Y-264.85
Assets Turnover0.00
Receivables Turnover13.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)123
Revenue per Share 0.00
Revenue Growth 3 Years -5.55
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.10-0.100.00
Q01 2018-0.10-0.14-40.00
Q04 2017--0.15-
Q02 2017-0.16-0.1412.50
Q01 2017-0.15-0.19-26.67
Q04 2016-0.22-0.1627.27
Q03 2016-0.16-0.23-43.75
Q02 2016-0.11-0.13-18.18
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.060.00-
12/2018 QR-0.05-25.00Negative
12/2018 FY-0.32-3.23Negative
12/2019 FY-0.1436.36Positive
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume5 998 385
Shares Outstanding (in ths.)97 840
Trades Count7 717
Dollar Volume10 281 991
Avg. Volume2 706 836
Avg. Weekly Volume8 695 905
Avg. Monthly Volume6 238 751
Avg. Quarterly Volume5 069 308

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

66%34%

Bearish Bullish

55%45%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x